| | No. of patients |
| | Age | | | Median | 50 | | Range | 25–73 |
| | Gender | | | Male | 12 | | Female | 12 |
| | Smoking | | | Never-smoker | 12 | | Light smoker (<10 pack years) | 8 |
| | Performance status | | | EGOG PS 0 | 5 | | 1 | 16 | | 2 | 3 |
| | Stage | | | III B “wet” | 1 | | IV | 23 |
| | Site(s) of metastatic disease | | | Bone | 17 | | Pleura and pericardium | 11 | | Distant lung | 11 | | Liver and/or suprarenals | 10 | | Distant lymph nodes and/or soft tissues | 6 | | Brain | 2 |
| | Number of metastatic sites | | | 1 | 8 | | 2 | 4 | | 3 or more | 12 |
|
|